Skip to main content

Efficient Construction Of A Large Naiive Phage Antibody Library

 Construction of the VH-VL Librrya

The goal is to generate an extensive Antibody Library of phage-displayed human scFV with a 6.7 * 109 member count that could serve the application in the respective industries and research laboratories. The Antibody Library is to be generated with improvising steps in library construction. Fourteen different protein antigens were under the affinity to select antibodies from the library. The goal is the generation of reagents from these large libraries that study the function of gene products identified by the genome projects.

Methods

  • Construction of the VH-VL Library.

Total RNA is prepared when different samples are taken from human spleen cells and human peripheral blood lymphocytes. The cDNA synthesised using the total RNA is primed with Human lgG Forward and Reverse primer. This VH-VL gene repertoire is amplified from  cDNA of Lymphocyte and cloned in Phagemid vector.

The resulting antibody gene library is transformed in E.coli TG1 cells and Phages are prepared to display the gene of VH-VL on Phages PIII gene which is tail of phages. 

  • Selection of Phage Antibodies.

Phagemid particles in the antibody library are rescued and scaled up. The specific phage-display scFV were selected with proteins that were affinity selected and are absorbed in Immunotubes. 

Immunotubes are coated overnight and purified from suspension culture. The phage eluted from each selection is put for transfecting E.coli TG1 cells. The rescue plating is done 3 to 4 times each to analyse specific antigen binding by ELISA technique till we achieve high binding clones.

  • Antibody Binding Specificity.

The antibody binding specificity is determined from all scFV by the ELISA technique, which is proceeded with using a target antigen that has nine different proteins than the desired ones as substrates in the process. The Antigen is subsequently reduced in concentration in order to achieve a very high affinity and specificity antibody.

  • scFv Purification and Affinity Measurements.

For purification, scFV genes are taken and subcloned, expressed, and purified to homogeneity. scFV dissociation equilibrium constants (Kd) is calculated from association constant (Ko) and dissociation (Koff) rate constants; these are determined with the surface plasmon resonance in a BIAcore.


Results

  • Library Construction.

The large antibody library was created when the routine isolation was done of high-affinity scFV antibodies on the target protein. The generated library plays a role in optimising every step that comes with library construction that promotes the efficiency of the scFV gene assembly and improvises the cloning.

These library generated products are of 12 ligation reactions that are associated with 36 electroporations. With the diverse repertoires created, there is V gene repertoires pool construction.

  • Selection and Characterization of Antigen-Specific scFv.

With the ELISA technique, the binding specificity of the antigen is used to recognise the different scFvs in and around the antigens. The small number of clones was the one selected after analysis, and the screening would yield more amount of additional antibodies. The binding of scFV with the antigens are the most specific one. These antibodies are further developed into different format and a recombinant clone is developed to produce IgG. These IgG developed are assessed on parameters for development of lead antibody drug molecule.

Discussion

The scFv large antibody library generated is efficient in producing the antibodies that could be used extensively. The difference in criteria and the validated results come with the above method for constructing the extensive antibody library. The rapid production of antibody libraries is set to affinity selection and recognises antigens at a higher percentage.

In addition, these antibodies and isolated scFVs serve as functional reagents with the different assays such as ELISA, immunofluorescence, Western Blotting, Epitope Mapping, and more.

At GeNext Genomics, we take pride in building Antibody Library that helps serve the industry with high-quality products and services. Our clients put a demand, and our skilled research scientists and experienced professionals know their way to build the required product.

We serve with utmost precision and develop an accurate Antibody Library that helps you reach your research goals and achieve milestones. We help the clients by serving them with industry standardised production that gives high-quality results.

Comments

Popular posts from this blog

Bacterial Zoonotic Diseases | Understanding the Risks and Prevention

  Bacterial zoonotic diseases are infections that can be transmitted from animals to humans. These diseases are caused by bacteria that are naturally present in animals, such as bacteria found in the gut, on the skin, or in saliva. Risks: The risk of infection from bacterial zoonotic diseases depends on various factors, including the type of bacteria, the animal host, and the mode of transmission. Some common bacterial zoonotic diseases include Salmonellosis, Campylobacteriosis, and Lyme disease. Prevention: To reduce the risk of infection from bacterial zoonotic diseases, the following precautions can be taken: Wash hands thoroughly after handling animals or animal products. Cook meat and eggs thoroughly before eating. Avoid close contact with animals that are sick or that carry diseases. Wear protective clothing and equipment when working with animals. Keep food and feed storage areas separate from animal areas. Prevent wildlife from accessing food storage areas. Regularly clea...

What is Humanized Monoclonal Antibody?

  A humanized monoclonal antibody is a type of protein that is produced in the laboratory using biotechnology techniques. It is made by modifying a monoclonal antibody that has been isolated from a mouse or other animal, so that it more closely resembles a human antibody. This is typically done by replacing certain amino acid sequences in the mouse antibody with sequences that are more similar to those found in human antibodies. Humanized Monoclonal Antibodies are used in a variety of medical applications, including the treatment of cancer and autoimmune diseases. They are also used as research tools in the development of new drugs and therapies. One of the main advantages of humanized monoclonal antibodies is that they are less likely to be rejected by the human immune system, compared to non-human antibodies. This makes them a promising option for the treatment of a wide range of diseases. There are several different approaches to creating humanized monoclonal antibodies, and re...
  What Is Chimeric Antibody? A chimeric antibody is a type of monoclonal antibody that is made up of parts that are both human and not human. It is made by putting together the variable region of a non-human antibody (which recognises and binds to specific antigens) and the constant region of a human antibody (which determines how the antibody works). Chimeric antibodies are meant to minimise the immunogenicity (the capacity to induce an immune response) of non-human antibodies, so making them safer and more effective for human therapeutic use. They have been used to treat cancer, autoimmune disorders, and infectious diseases, among other things. Check out Genext Genomics to know more.